Death from acute pancreatitis. M.R.C. multicentre trial of glucagon and aprotinin.

  • 24 September 1977
    • journal article
    • clinical trial
    • Vol. 2  (8039) , 632-5
Abstract
The influence of glucagon and aprotinin ('Trasylol') on the death-rate of acute pancreatitis has been studied in a randomised double-blind multicentre trial. The death-rate in 257 patients was 11%. In the doses used neither drug was found to diminish the risk of death.

This publication has 0 references indexed in Scilit: